Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Brian Angus.

Newcastle AuthorsTitleYearFull text
Dr Michal Sieniawski
Dr Brian Angus
Professor Stephen Proctor
Dr Anne Lennard
Impact of p53 positive p21 negative phenotype on outcome in CHOP-R treated DLBCL patients2014
Dr Rachel Crossland
Dr Michal Sieniawski
Dr Brian Angus
Professor Stephen Proctor
Dr Paul Milne
et al.
Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B-cell lymphoma patients2013
Dr Rachel Crossland
Dr Michal Sieniawski
Dr Brian Angus
Dr Susan Proctor
Kate McCabe
et al.
Mature microRNAs of the miR-17-92 cluster predict for disease outcome in diffuse large B-cell lymphoma (DLBCL) patients treated with CHOP-R immunochemotherapy2011
Dr Mary Slatter
Dr Brian Angus
Dr Kevin Windebank
Professor Sophie Hambleton
Dr Mario Abinun
et al.
Polymorphous lymphoproliferative disorder with Hodgkin-like features in common gamma-chain-deficient severe combined immunodeficiency2011
Dr Rachel Crossland
Dr John Anderson
Dr Brian Angus
Professor Stephen Proctor
Dr Stephen Crosier
et al.
A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines2010
Dr Rachel Crossland
Professor Stephen Proctor
Dr Brian Angus
Dr Stephen Crosier
Dr John Anderson
et al.
A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines2010
Dr Rachel Crossland
Dr John Anderson
Dr Brian Angus
Professor Stephen Proctor
Dr Stephen Crosier
et al.
A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines2010
Dr John Anderson
Lynne Overman
Dr Katrina Wood
Professor Stephen Proctor
Dr Stephen Crosier
et al.
Immunophenotyping of diffuse large B-cell lymphoma (DLBCL) defines multiple sub-groups of germinal centre-like tumours displaying different survival characteristics2009
Dr Kevin Windebank
Dr Brian Angus
Dr Mario Abinun
Dr Terence Flood
Professor Andrew Cant
et al.
Malignancy as a presentation of common gamma chain deficient severe combined immunodeficiency2009
Dr Tryfonia Mainou-Fowler
Lynne Overman
Dr Katrina Wood
Dr Brian Angus
Professor Stephen Proctor
et al.
A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-22008
Dr Kevin Windebank
Dr Brian Angus
Dr Petra Dildey
Dr Mario Abinun
Dr Terence Flood
et al.
Malignancy as a presentation of common gamma chain deficient severe combined immunodeficiency2008
Seamus Kelly
Dr John Anderson
Dr Brian Angus
Dr Christine Challen
Professor John Lunec
et al.
The predictive value of p53 and p33ING1b in patients with Dukes'C colorectal cancer2008
Dr Tryfonia Mainou-Fowler
Lynne Overman
Dr Katrina Wood
Dr Stephen Crosier
Dr Brian Angus
et al.
A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-22007
Dr Brian Angus
Dr Patrick Kesteven
Localized reactive angioendotheliomatosis2007
Dr Penelope Taylor
Dr Kevin Windebank
Dr Helen Lucraft
Dr Katrina Wood
Dr Brian Angus
et al.
Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents2007
Dr Brian Angus
Dr Penelope Taylor
Impact of tumor EBV status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma2006
Dr Tryfonia Mainou-Fowler
Dr Brian Angus
Professor Stephen Proctor
Dr Penelope Taylor
Dr Katrina Wood
et al.
Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PdEGF) in classical Hodgkin lymphoma (HL)2006
Dr Penelope Taylor
Dr Brian Angus
Professor Graham Jackson
Dr Helen Lucraft
Professor Stephen Proctor
et al.
The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial2006
Dr Brian Angus
Dr Andrew Carmichael
A case of Schopf-Schulz-Passarge syndrome2005
Dr Brian Angus
Dr Penelope Taylor
Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study2005
Professor Stephen Proctor
Dr Brian Angus
Dr Katrina Wood
Dr Tryfonia Mainou-Fowler
Microvessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PDEGF) in classical Hodgkin lymphoma (HL)2005
Professor Andrew Gennery
Dr Simon Harris
Dr Brian Angus
Professor Andrew Cant
Omenn's syndrome occurring in patients without mutations in recombination activating genes2005
Dr John Anderson
Dr Stephen Crosier
Lynne Overman
Dr Tryfonia Mainou-Fowler
Dr Sarah Fordham
et al.
Survivin in diffuse large B cell lymphoma: Evaluation as a prognostic marker2005
Dr Brian Angus
An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD): Evidence for a specific association with EBV+ve HD in young adults2003
Dr John Anderson
Dr Stephen Crosier
Dr Jyotsna Shrimankar
Professor John Lunec
Dr Brian Angus
et al.
Downregulation of nuclear expression of the p33ING1b inhibitor of growth protein in invasive carcinoma of the breast2003
Dr Brian Angus
Dr Clifford Lawrence
Histopathological assessment of tissue damage caused by electrodesiccation and fulguration2003
Dr Stephen Crosier
Dr Katrina Wood
Dr Philip Taylor
Professor Stephen Proctor
Dr Brian Angus
et al.
IAP survivin in diffuse large B cell lymphoma: Evaluation as a prognostic marker2003
Dr Brian Angus
Dr Gavin Spickett
Lymphoproliferative disease in antibody deficiency: a multi-centre study2003
Professor Stephen Proctor
Professor Graham Jackson
Dr Anne Lennard
Dr Brian Angus
Dr Katrina Wood
et al.
Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK)2003
Dr John Anderson
Professor John Lunec
Dr Brian Angus
The role of the tumour suppressor p33ING1b in human neoplasia2003
Dr Brian Angus
Dr Penelope Taylor
The Scotland and Newcastle epidemiological study of Hodgkin's disease: Impact of histopathological review and EBV status on incidence estimates2003
Andrew Lodge
Dr John Anderson
Dr Beate Haugk
Dr Brian Angus
Type 1 growth factor receptor expression in node positive breast cancer: Adverse prognostic significance of c-erbB-42003
Professor Muzlifah Haniffa
Dr Brian Angus
Dr Simon Meggitt
Warty granuloma faciale2003
Professor Stephen Proctor
Dr Brian Angus
Professor Graham Jackson
Dr Anne Lennard
Dr Penelope Taylor
et al.
A population-based study of intensive multi-agent chemotherapy with or without autotransplant for the highest risk Hodgkin's disease patients identified by the Scotland and Newcastle Lymphoma Group (SNLG) prognostic index. A Scotland and Newcastle Lymphoma Group study (SNLG HD III)2002
Dr Brian Angus
Professor John Lunec
Dr Stephen Crosier
Andrew Lodge
Dr John Anderson
et al.
Comparative assessment expression of the inhibitor of growth 1 gene (ING1) in normal and neoplastic tissues2002
Dr Gail Stark
Dr Katrina Wood
Dr Fergus Jack
Dr Brian Angus
Professor Stephen Proctor
et al.
Hodgkin's disease in the elderly: a population-based study2002
Dr Fergus Jack
Dr Brian Angus
Immunohistochemical detection of CD30 remains negative in nodular lymphocyte-predominant Hodgkin's disease using enhanced antigen retrieval2002
Dr John Anderson
Dr Katrina Wood
Professor John Lunec
Emeritus Professor Andy Hall
Dr Michael Reid
et al.
Loss of nuclear expression of the p33ING1b inhibitor of growth protein in childhood acute lymphoblastic leukaemia2002
Dr John Anderson
Dr Marie Mathers
Dr Niamh Leonard
Dr Stephen Crosier
Professor John Lunec
et al.
Nuclear to cytoplasmic compartment shift of the p33ING1b tumour suppressor protein is associated with malignancy in melanocytic lesions2002
Seamus Kelly
Dr John Anderson
Dr Brian Angus
Professor John Lunec
p33/ING1 nuclear expression and TP53 gene mutation in colorectal cancer and their association with clinical outcome2002
Dr John Anderson
Dr Stephen Crosier
Dr Jyotsna Shrimankar
Professor John Lunec
Dr Brian Angus
et al.
p33ING1b tumour suppressor immunohistochemical expression in invasive breast carcinomas2002
Seamus Kelly
Dr John Anderson
Dr Brian Angus
Professor John Lunec
TP53 and p33(Ing1) are co-determinants of prognosis in colorectal cancer2002
Dr Stephen Crosier
Dr Brian Angus
Dr John Anderson
Use of transgenomic wave and denaturing gel electrophoresis increases the sensitivity of FR3A-FR4 PCR detection of B-cell clonality2002
Dr Brian Angus
Professor David Neal
Professor John Lunec
Kilian Mellon
Cyclin D1 expression in transitional cell carcinoma of the bladder: Correlation with p53, waf1, pRb and Ki672001
Professor John Lunec
Seamus Kelly
Dr John Anderson
Dr Brian Angus
Expression of p33/ING1 gene products in colorectal cancer and its correlation with survival2001
Dr John Anderson
Professor John Lunec
Emeritus Professor Andy Hall
Dr Michael Reid
Dr Brian Angus
et al.
p33(ING1b) tumour suppresser protein expression in childhood acute lymphoblastic leukaemia by immunohistochemistry2001
Dr Stephen Crosier
Dr John Anderson
Dr Marie Mathers
Dr Niamh Leonard
Dr Stephen Crosier
et al.
p33(ING1b) tumour suppresser protein expression in melanocytic lesions, an immunohistochemical study of 67 cases2001
Seamus Kelly
Professor John Lunec
Dr John Anderson
Dr Brian Angus
p33/ING1 nuclear expression in colorectal cancer and its correlation with metastasis and survival2001
Dr John Anderson
Dr Stephen Crosier
Professor John Lunec
Dr Brian Angus
p33ING1b tumour suppresser protein expression in thyroid lesions determined by immunohistochemistry2001
Dr Marie Mathers
Dr Jyotsna Shrimankar
Dr David Scott
Dr Fraser Charlton
Clive Griffith
et al.
The use of a standard proforma in breast cancer reporting2001
Dr Claire Bethune
Dr Brian Angus
Dr Gavin Spickett
Treatment of EBV driven lymphoproliferation with erythrophagocytosis: 12 year follow up2001
Dr Brian Angus
Professor Andrew Cant
Cytomegalovirus infection in infants with autoimmune lymphoproliferative syndrome (ALPS)2000
Andrew Lodge
Dr John Anderson
Dr Beate Haugk
Dr Brian Angus
Expression of topoisomerase III alpha in normal and neoplastic tissues determined by immunohistochemistry using a novel monoclonal antibody2000
Andrew Lodge
Dr John Anderson
Dr Beate Haugk
Dr Brian Angus
Expression of topoisomerase IIIα in normal and neoplastic tissues determined by immunohistochemistry using a novel monoclonal antibody2000
Dr Brian Angus
Dr Fergus Jack
Professor Graham Jackson
Professor Stephen Proctor
Dr Penelope Taylor
et al.
Improved estimation of tumour burden leads to better prognostic discrimination in classical hodgkin's disease in adults2000
Dr Brian Angus
Dr Bridget Wilkins
Molecular analysis reveals somatically mutated and unmutated clonal and oligoclonal B cells in T-cell-rich B-cell lymphoma2000
Dr Brian Angus
Professor John Lunec
Dr John Anderson
Monoclonal antibodies raised to products of the ING1 tumour suppressor gene locus.2000
Andrew Lodge
Dr John Anderson
Dr Brian Angus
Pixel-based image cytometry for quantification of nuclear antigen expression using Adobe Photoshop2000
Dr John Anderson
Dr Brian Angus
Professor John Lunec
Sequencing of ING1 tumour suppressor gene cDNAs generated from mRNA recovered from normal and neoplastic cell lines.2000
Andrew Lodge
Dr John Anderson
Dr Beate Haugk
Dr Brian Angus
Type 1 growth factor receptor and topoisomerase expression in breast cancer: Adverse prognostic significance of c-erbB-42000
Dr Brian Angus
Dr Sathyarathna Gokul
Professor Alan Calvert
Professor John Lunec
Bcl-2 expression is a potential prognostic co-factor with P53- mutation status in epithelial ovarian carcinoma1999
Dr Debbie Scott
Dr Brian Angus
Cyclin D1 expression in usual hyperplasia, atypical ductal hyperplasia and low nuclear grade ductal carcinoma in situ of the breast: an immunohistochemical study1999
Dr Ian Brotherick
Dr Brian Shenton
Dr Brian Angus
Jagnohan Varma
Professor Frederick Campbell
et al.
Cyclin D3 expression, cell proliferation and pathological stage of human primary colorectal cancer1999
Dr Craig Dixon
Dr Simon Sinclair
Dr Fraser Charlton
Dr John Anderson
Professor Peter Farr
et al.
Diagnosis of mycosis fungoides using histological evaluation, immunophenotyping and molecular analysis in formalin-fixed, parafin-embedded tissue1999
Abid Sattar
Professor Steve Robson
Dr Brian Angus
Professor Frederick Campbell
Expression of growth regulatory genes in a SCID mouse-human model of intestinal epithelial regeneration1999
Andrew Lodge
Emeritus Professor Andy Hall
Dr Katrina Wood
Dr John Anderson
Dr Brian Angus
et al.
NCL-CD10-270: A new monoclonal antibody recognizing CD10 in paraffin- embedded tissue1999
Dr Fergus Jack
Dr Brian Angus
Dr Penelope Taylor
Prognostic score for Hodgkin's disease1999
Dr Fergus Jack
Dr Brian Angus
Signal amplification using biotinylated tyramide for detection of CD 30 and epithelial membrane antigen in nodular lymphocyte predominant Hodgkin's disease1999
Helen Bell
Dr Brian Angus
The value of BCL-6 expression in the differential diagnosis of small B cell lymphoma.1999
Andrew Lodge
Emeritus Professor Andy Hall
Dr John Anderson
Dr Michael Reid
Dr Brian Angus
et al.

A study of the prognostic significance of topoisomerase IIα in childhood acute lymphoblastic Leukaemia

1998
Professor Stephen Proctor
Dr Penelope Taylor
Dr Brian Angus
A prospective evaluation of the use of a numerical prognostic index for patient management in the context of a population-adjusted clinical epidemiology (PACE) study in the Northern Region, UK1998
Dr Brian Angus
Professor David Neal
Professor John Lunec
Kilian Mellon
Cyclin Dl expression in TCC of the bladder: Correlation with WAF1, p53 and Ki671998
Dr John Anderson
Dr William Cowan
William Cunliffe
Dr Brian Angus
ER-CARD: a more sensitive method for detection of oestrogen receptor by immunohistochemistry1998
Professor Julie Irving
Gerard Cain
Dr Brian Angus
Dr Penelope Taylor
The role of alternative splicing of the adhesion molecule, CD44, in lymphoid malignancy1998
Dr John Anderson
Professor Thomas Lennard
Dr Brian Angus
A novel quantitative immunoassay system for p53 using antibodies selected for optimum designation of p53 status1997
Professor Graham Jackson
Dr Philip Taylor
Dr David Goff
Dr Anne Lennard
Dr Brian Angus
et al.
High dose ifosfamide in combination with etoposide and epirubicin in the treatment of relapsed/refactory Hodgkin's disease: A report on toxicity and efficacy.1997
Professor Debra Bevitt
Professor Geoff Toms
Professor Thomas Lennard
Professor Bruce Westley
Dr Brian Angus
et al.
New monoclonal antibodies to oestrogen and progesterone receptors effective for paraffin section immunohistochemistry1997
Dr Mark Egan
Dr John Anderson
Dr William Cowan
Dr Brian Angus
Optimised determination of vascular invasion in breast cancer by immunohistochemistry for CD31: production of a novel monoclonal antibody and comparison with conventional assessment.1997
Professor Nick Reynolds
Carole Todd
Dr Brian Angus
Overexpression of protein kinase C-α and -β isozymes by stromal dendritic cells in basal and squamous cell carcinoma1997
Alan Adams
Dr Brian Angus
Dr Gajanan Sherbet
Professor Thomas Lennard
Prediction of nodal metastasis and prognosis in breast cancer: A neural model1997
Professor Julie Irving
Gerard Cain
Dr Brian Angus
The role of alternative splicing of the adhesion molecule, CD44 in lymphoid malignancy1997
Dr John Anderson
Dr Brian Angus
Determination of the clinical significance of cyclin a expression in human breast cancer using a novel monoclonal antibody1996
Professor Julie Irving
Gerard Cain
Dr Brian Angus
OCT embedded sections of pathological specimens as a source of high quality RNA for reverse transcriptase/polymerase chain reaction1996
Dr John Anderson
Dr Brian Angus
Professor Thomas Lennard
p53 protein as a prognostic indicator in breast carcinoma: A comparison of four antibodies for immunohistochemistry1996
Dr John Anderson
Professor Thomas Lennard
Dr Brian Angus
Retinoblastoma protein in human breast carcinoma: Immunohistochemical study using a new monoclonal antibody effective on routinely processed tissues1996
Alan Adams
Dr Brian Angus
Dr Gajanan Sherbet
Professor Thomas Lennard
The detection of nodal metastasis in breast cancer using neural network techniques1996
Dr Mark Levasseur
Dr Peter Middleton
Dr Brian Angus
Professor Stephen Proctor
Jean Norden
et al.

c-MYC gene abnormalities in high grade and centroblastic-centrocytic Non-Hodgkins Lymphoma

1995
Dr John Anderson
Dr Brian Angus
Professor Thomas Lennard

Determination of the prognostic value of cyclin D1 overexpression in breast cancer

1995
Dr Ian Brotherick
Dr Brian Shenton
Dr William Cowan
Dr Brian Angus
Professor Thomas Lennard
et al.

P53 expression measured by flow cytometry: a comparison of 3 monoclonal antibodies and the relationship with grade and DNA ploidy in breast cancer

1995
Dr Ian Brotherick
Dr Brian Shenton
Dr Brian Angus
Ian Waite
Professor Thomas Lennard
et al.
A flow cytometric study of c-erbB-3 expression in breast cancer1995
Dr Ian Brotherick
Dr Brian Shenton
Dr William Cowan
Dr Brian Angus
Professor Thomas Lennard
et al.
Relationship between flow cytometric and immunohistochemically detected C-ERBB-2 expression, grade and DNA ploidy in breast cancer1995
Dr Anne Lennard
Dr Brian Angus
Professor Stephen Proctor

Prognostic Significance of Epstein Barr Virus Association in Hodgkins Disease

1994
Professor Graham Jackson
Dr Anne Lennard
Dr Penelope Taylor
Dr Peter Carey
Dr Brian Angus
et al.
Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission1994
Dr John Anderson
Dr Christopher Wright
Dr Brian Angus
NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study1994
Dr Penelope Taylor
Professor Graham Jackson
Dr Anne Lennard
Dr Helen Lucraft
Professor Stephen Proctor
et al.
Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue1993
Dr Brian Angus
Dr Christopher Wright
Professor Thomas Lennard
Dr Ian Corbett

Retinoblastoma and P53 gene expression related to relapse and survival in human breast cancer - an immunohistochemical study

1992
Dr Felicity May
Professor Bruce Westley
Dr Brian Angus
Professor Thomas Lennard

Expression of antimetastatic gene NM23

1991
Dr Felicity May
Professor Bruce Westley
Dr Brian Angus
Professor Thomas Lennard

Expression of the antimetastatic gene NM23 in human breast cancer: an association with good prognosis

1991
Professor Thomas Lennard
Dr Brian Angus

P53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study

1991
Dr Brian Angus
Diana Levett
Dr Sarah Johnson
Professor Thomas Lennard
Dr Felicity May
et al.

The prognostic significance of the lysosomal protease cathepsin-D in human breast cancer - an immunohistochemical study

1991
Dr Roger Dykins
Dr Ian Corbett
Dr Christopher Wright
Professor Thomas Lennard
Dr Brian Angus
et al.
Long-term survival in breast cancer related to overexpression of the C-ERBB-1 oncoprotein - an immunohistochemical study using monoclonal antibody NCL-CB11 1991
Dr Brian Angus
Professor Bruce Westley
Dr Felicity May
Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study.
1990
Dr Christopher Wright
Dr Ian Corbett
Dr Brian Angus
Professor Thomas Lennard

C-ERBB-2 oncoprotein expression in mammary and extramammary pagets disease - an immunohistochemical study

1990
Craig Wright
Dr Ian Corbett
Professor Thomas Lennard
Dr Brian Angus

C-ERBB-2 Oncoprotein expression in mammary and extramammary pagets disease determined by immunohistochemistry using the novel monoclonal antibody NCL-CB11

1990
Dr Ian Corbett
Dr Brian Angus
Dr Felicity May
Professor Bruce Westley

NCL-CB11 anto c-erbb-2 monoclonal antibody characterization and correlation with gene amplification

1990
Dr Ian Corbett
Dr Brian Angus
Dr Felicity May
Professor Bruce Westley

NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbb-2 oncogene protein effective for use on formalin fixed, paraffin embedded tissue

1990
Dr Felicity May
Professor Bruce Westley
Dr Brian Angus
Professor Thomas Lennard

The antimetastatic gene NM23: its expression in human breast cancers

1990
Dr Ian Corbett
Dr Christopher Wright
Professor Thomas Lennard
Dr Brian Angus
c-erbB-2 oncoprotein expression related to hitological type in breast cancer: an immunohistochemical study.1990
Dr Brian Angus
Emeritus Professor Andy Hall
Professor Stephen Proctor
Glutathione S-transferase (placental) as a marker of transformation in the human cervix uteri: an immunohistochemical study1990
Dr Anne Lennard
Professor Stephen Proctor
Dr Brian Angus
Dr Helen Lucraft
Lomustine, vindesine and bleomycin (LVB) used in the treatment of relapsed advanced Hodgkin's disease: A prospective study on behalf of the east of Scotland and Newcastle lymphoma group (ESNLG)1989
Dr Mary Robinson
Dr Brian Angus
Professor Stephen Proctor
Lymphocyte depleted Hodgkins disease: A retrospective immunohistological study1987